fluconazole has been researched along with thiazoles in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (28.57) | 18.2507 |
2000's | 15 (42.86) | 29.6817 |
2010's | 9 (25.71) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Bhakdi, S; Jahn, B; Martin, E; Stueben, A | 1 |
Acosta, D; Rodriguez, RJ | 1 |
Hata, K; Katsu, K; Kimura, J; Miki, H; Nakamura, T; Toyosawa, T | 1 |
Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T | 1 |
Clancy, CJ; Nguyen, MH | 1 |
Aoki, FH; Branchini, ML; Mikami, Y; Miyaji, M; Nishimura, K; Taguchi, H; Yamamoto, K; Yang, HC; Yazawa, K | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Diekema, DJ; Doern, GV; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Bujdáková, H; Dierich, MP; Gruber, A; Klobusický, M; Kurisková, S; Langgartner, M; Lell, CP; Spötl, L; Würzner, R | 1 |
Bonner, DP; Fung-Tomc, JC; Huczko, E; Minassian, B; White, TC | 1 |
Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T | 1 |
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
Calderon, L; Clemons, KV; Martinez, M; Stevens, DA | 1 |
Kamei, K | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S | 1 |
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
Bujdáková, H; Melkusová, S; Mikami, Y; Myoken, Y; Volleková, A | 1 |
Perfect, JR | 1 |
Batra, R; Gupta, AK; Kohli, Y | 1 |
Steinbach, WJ | 1 |
Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Ayala, J; Elizondo, M; González, GM | 1 |
Abruzzetti, A; Arzeni, D; Barchiesi, F; Castelletti, S; Cirioni, O; Ganzetti, G; Giacometti, A; Kamysz, E; Kamysz, W; Offidani, AM; Riva, A; Scalise, G; Silvestri, C; Simonetti, O; Spreghini, E | 1 |
Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
Arridu, A; Bianco, G; Corona, A; Cottiglia, F; De Logu, A; Distinto, S; Maccioni, E; Matyus, P; Meleddu, R; Melis, C; Sanna, A | 1 |
Goldsmith, P; Nasir, S | 1 |
Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
Basaric, J; Billack, B; Lau-Cam, C; Młochowski, J; Orie, NN; Piętka-Ottlik, M; Warren, AR | 1 |
Aluri, J; Boyd, P; Chang, MK; Ferry, J; Lai, WG; Nomoto, M; Rege, B; Schuck, E; Siu, YA; Yasuda, S; Zamora, CA | 1 |
Cheng, X; Ishita, K; Khalil, A; Rappleye, CA; Stefanopoulos, S; Tjarks, W | 1 |
Eweis, M; Gomha, SM; Ouf, AS; Ouf, SA; Sharawy, IA | 1 |
Konishi, K; Minematsu, T; Nagasaka, Y; Tabata, K | 1 |
Abutaleb, NS; Hagras, M; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
4 review(s) available for fluconazole and thiazoles
Article | Year |
---|---|
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
1 trial(s) available for fluconazole and thiazoles
Article | Year |
---|---|
Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.
Topics: Adolescent; Adult; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Healthy Volunteers; Humans; Itraconazole; Male; Middle Aged; Platelet Count; Receptors, Thrombopoietin; Rifampin; Thiazoles; Thiophenes; Young Adult | 2018 |
30 other study(ies) available for fluconazole and thiazoles
Article | Year |
---|---|
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.
Topics: Amphotericin B; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluconazole; Formazans; Itraconazole; Microbial Sensitivity Tests; Mitochondria; Tetrazolium Salts; Thiazoles; Vitamin K | 1995 |
Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes.
Topics: Analysis of Variance; Animals; Cell Membrane Permeability; Cells, Cultured; Fluconazole; Ketoconazole; L-Lactate Dehydrogenase; Liver; Lysosomes; Mitochondria, Liver; Neutral Red; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 1995 |
In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles | 1996 |
Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Coloring Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Spectrophotometry; Tetrazolium Salts; Thiazoles | 1997 |
Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Colorimetry; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Tetrazolium Salts; Thiazoles; Triazoles | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Thiazoles; Triazoles | 1999 |
The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Clotrimazole; Complement C3b; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Fluconazole; Humans; Immunoblotting; Microbial Sensitivity Tests; Nystatin; Receptors, Complement 3b; Rosette Formation; Sheep; Species Specificity; Thiazoles; Tunicamycin | 1999 |
In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1999 |
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole | 2001 |
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Histoplasmosis; Itraconazole; Liver; Mice; Spleen; Survival; Survival Analysis; Thiazoles; Triazoles | 2002 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles; Yeasts | 2004 |
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Thiazoles | 2004 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Topics: Antifungal Agents; Arthrodermataceae; Biomass; Cyclohexane Monoterpenes; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Microsporum; Monoterpenes; Mycoses; Tetrazolium Salts; Thiazoles; Trichophyton | 2009 |
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Chlorocebus aethiops; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Thiazoles; Vero Cells | 2016 |
Anogenital allergic contact dermatitis caused by methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthem triggered by oral fluconazole.
Topics: Adult; Antifungal Agents; Anus Diseases; Clotrimazole; Dermatitis, Allergic Contact; Drug Eruptions; Female; Fluconazole; Humans; Patch Tests; Preservatives, Pharmaceutical; Thiazoles; Vulvar Diseases | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
In vitro assessment of the growth and plasma membrane H
Topics: Antifungal Agents; Azoles; Candida albicans; Cell Membrane; Culture Media, Conditioned; Drug Resistance, Fungal; Drugs, Investigational; Enzyme Inhibitors; Fluconazole; Fungal Proteins; Heterocyclic Compounds, 2-Ring; Hydrogen-Ion Concentration; Isoindoles; Kinetics; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Organoselenium Compounds; Proton-Translocating ATPases; Thiazoles | 2017 |
Synthesis and biological evaluation of aminothiazoles against Histoplasma capsulatum and Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Chromatography, Affinity; Cryptococcus neoformans; Drug Design; Fluconazole; Histoplasma; Macrophages; Mice; Microbial Sensitivity Tests; Naphthalenes; Solubility; Structure-Activity Relationship; Thiazoles | 2018 |
Efficiency of newly prepared thiazole derivatives against some cutaneous fungi.
Topics: Animals; Antifungal Agents; Binding Sites; Candida albicans; Fluconazole; Fungal Proteins; Guinea Pigs; Hydrogen Bonding; Microbial Sensitivity Tests; Microsporum; Molecular Docking Simulation; Peptide Hydrolases; Protein Structure, Tertiary; Skin Diseases; Structure-Activity Relationship; Thiazoles; Trichophyton | 2018 |
Physiologically-based pharmacokinetic modeling for mirabegron: a multi-elimination pathway mediated by cytochrome P450 3A4, uridine 5'-diphosphate-glucuronosyltransferase 2B7, and butyrylcholinesterase.
Topics: Acetanilides; Butyrylcholinesterase; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Glucuronosyltransferase; Humans; Models, Biological; Reproducibility of Results; Thiazoles | 2019 |
Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Resistance, Multiple; Fluconazole; Humans; Microbial Sensitivity Tests; Mycoses; Thiazoles | 2021 |